| Metabolomic profile of glycolysis and the pentose phosphate pathway identifies the central role of glucose-6-phosphate dehydrogenase in clear cell-renal cell carcinoma G Lucarelli, V Galleggiante, M Rutigliano, F Sanguedolce, S Cagiano, ... Oncotarget 6 (15), 13371, 2015 | 180 | 2015 |
| Oral L-citrulline supplementation improves erection hardness in men with mild erectile dysfunction L Cormio, M De Siati, F Lorusso, O Selvaggio, L Mirabella, ... Urology 77 (1), 119-122, 2011 | 156 | 2011 |
| Pentraxin 3: a novel biomarker for predicting progression from prostatic inflammation to prostate cancer G Stallone, L Cormio, GS Netti, B Infante, O Selvaggio, GD Fino, E Ranieri, ... Cancer research 74 (16), 4230-4238, 2014 | 105 | 2014 |
| Activation of the kynurenine pathway predicts poor outcome in patients with clear cell renal cell carcinoma G Lucarelli, M Rutigliano, M Ferro, A Giglio, A Intini, F Triggiano, ... Urologic Oncology: Seminars and Original Investigations 35 (7), 461. e15-461 …, 2017 | 98 | 2017 |
| Urine TMPRSS2: ERG fusion transcript as a biomarker for prostate cancer: literature review F Sanguedolce, A Cormio, M Brunelli, A D'Amuri, G Carrieri, P Bufo, ... Clinical genitourinary cancer 14 (2), 117-121, 2016 | 89 | 2016 |
| Combined use of prostate-specific antigen density and magnetic resonance imaging for prostate biopsy decision planning: a retrospective multi-institutional study using the … UG Falagario, I Jambor, A Lantz, O Ettala, A Stabile, P Taimen, HJ Aronen, ... European urology oncology 4 (6), 971-979, 2021 | 71 | 2021 |
| Aberrant DNA hypermethylation of hMLH-1 and CDKN2A/p16 genes in benign, premalignant and malignant endometrial lesions. M Guida, F Sanguedolce, P Bufo, ADS Sardo, G Bifulco, C Nappi, ... Eur. J. Gynaec. Oncol.-ISSN 30 (3), 2009, 2009 | 70 | 2009 |
| NY‐ESO‐1/LAGE‐1 coexpression with MAGE‐A cancer/testis antigens: A tissue microarray study M Bolli, E Schultz‐Thater, P Zajac, U Guller, C Feder, F Sanguedolce, ... International journal of cancer 115 (6), 960-966, 2005 | 70 | 2005 |
| Role of Runx2 phosphorylation in prostate cancer and association with metastatic disease C Ge, G Zhao, Y Li, H Li, X Zhao, G Pannone, P Bufo, A Santoro, ... Oncogene 35 (3), 366-376, 2016 | 66 | 2016 |
| Prostate cancer detection rates in different biopsy schemes. Which cores for which patients? L Cormio, V Scattoni, F Lorusso, A Perrone, G Di Fino, O Selvaggio, ... World journal of urology 32, 341-346, 2014 | 64 | 2014 |
| A troubling diagnosis of verrucous squamous cell carcinoma (“the bad kind” of keratosis) and the need of clinical and pathological correlations: a review of the literature with … A Santoro, G Pannone, M Contaldo, F Sanguedolce, V Esposito, ... Journal of skin cancer 2011 (1), 370605, 2011 | 62 | 2011 |
| Altered p53 and pRb expression is predictive of response to BCG treatment in T1G3 bladder cancer L Cormio, I Tolve, P Annese, A Saracino, R Zamparese, F Sanguedolce, ... Anticancer Research 29 (10), 4201-4204, 2009 | 62 | 2009 |
| Prognostic significance of N-Cadherin expression in oral squamous cell carcinoma M Di Domenico, GM Pierantoni, A Feola, F Esposito, L Laino, A De Rosa, ... Anticancer Research 31 (12), 4211-4218, 2011 | 61 | 2011 |
| Reduced percentage of natural killer cells associated with impaired cytokine network in the secretory endometrium of infertile women with polycystic ovary syndrome M Matteo, G Serviddio, F Massenzio, G Scillitani, L Castellana, G Picca, ... Fertility and sterility 94 (6), 2222-2227. e3, 2010 | 60 | 2010 |
| Increased expression of the autocrine motility factor is associated with poor prognosis in patients with clear cell–renal cell carcinoma G Lucarelli, M Rutigliano, F Sanguedolce, V Galleggiante, A Giglio, ... Medicine 94 (46), e2117, 2015 | 55 | 2015 |
| Urinary RKIP/p-RKIP is a potential diagnostic and prognostic marker of clear cell renal cell carcinoma M Papale, G Vocino, G Lucarelli, M Rutigliano, M Gigante, MT Rocchetti, ... Oncotarget 8 (25), 40412, 2017 | 54 | 2017 |
| Predictive markers in bladder cancer: do we have molecular markers ready for clinical use? F Sanguedolce, P Bufo, G Carrieri, L Cormio Critical reviews in clinical laboratory sciences 51 (5), 291-304, 2014 | 54 | 2014 |
| Epigenetic fingerprint in endometrial carcinogenesis: the hypothesis of a uterine field cancerization M Di Domenico, A Santoro, C Ricciardi, M Iaccarino, S Iaccarino, M Freda, ... Cancer biology & therapy 12 (5), 447-457, 2011 | 53 | 2011 |
| Altered expression of HER-2 and the mismatch repair genes MLH1 and MSH2 predicts the outcome of T1 high-grade bladder cancer F Sanguedolce, A Cormio, P Massenio, MC Pedicillo, S Cagiano, ... Journal of cancer research and clinical oncology 144, 637-644, 2018 | 49 | 2018 |
| Molecular markers in bladder cancer: Novel research frontiers F Sanguedolce, A Cormio, P Bufo, G Carrieri, L Cormio Critical reviews in clinical laboratory sciences 52 (5), 242-255, 2015 | 49 | 2015 |
